• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
On January 12th, Goldman Sachs Chief Economist Jan Hatzius stated that the threat of criminal prosecution against the Federal Reserve Chairman will exacerbate market concerns about the central banks independence, but he expects the Fed to continue making policy decisions based on economic data. Speaking at the Goldman Sachs Global Strategy Conference in 2026, Hatzius said, "Clearly, concerns about a potential blow to the Feds independence are increasing, and the latest news regarding the criminal investigation of Chairman Powell has further reinforced these concerns." He added, "I have no doubt that Powell will continue to make decisions based on economic data for the remainder of his term, and will not be swayed in any direction by pressure—whether its raising or lowering interest rates, it will follow data guidance."On January 12th, ABN Amro economist Roger Quedflich stated in a report that the investigation into Federal Reserve Chairman Jerome Powell could jeopardize the Feds prospects for interest rate cuts in the near term. He pointed out that the challenge to the Feds independence could prompt Fed governors to take a hardline stance, delaying rate cut decisions to "defend the Fed." The investigation concerns cost overruns in a Fed headquarters renovation project, which Quedflich believes is seen as a means to pressure the Fed chairman and force his resignation, thereby expanding government influence. He stated, "If the situation continues to escalate, rate cuts may be postponed."On January 12th, ING FX strategist Francesco Pesole stated in a report that the dollar faces a significant risk of decline after Federal Reserve Chairman Jerome Powell announced that the Fed had received a subpoena from the U.S. Department of Justice for overspending on its headquarters renovations. He pointed out that this move has reignited market concerns about the Feds independence and could trigger another "sell-America" trade. Pesole stated, "Any further signs of interference in the Feds independence will pose a considerable downside risk to the dollar."ECB Governing Council member Mueller: There is no reason for further interest rate cuts in the short term.January 12th - According to the "Beijing Cyberspace Administration," as of January 12, 2026, Beijing has added 3 new generative artificial intelligence services that have completed registration, bringing the total number of registered generative artificial intelligence services to 212.

NASDAQ, S&P 500, Dow Jones Analysis – NASDAQ Rallies As Meta Gains 28%

Jimmy Khan

Feb 03, 2023 15:22

微信截图_20230203151224.png

S&P 500

As Meta increased by 28% following the publication of the earnings report, the S&P 500 reached new heights. Although the company's revenue exceeded analyst expectations, its earnings missed them. Trades concentrated on the $40 billion buyback that Meta had announced.


The Initial Jobless Claims and Factory Orders figures were also available to dealers today.


Compared to the analyst consensus of 200,000, the initial Jobless Claims report showed that 183,000 Americans applied for unemployment benefits in a week. According to the report, the job market was still in a respectable state.


In December, factory orders grew by 1.8% month over month compared to analysts' expectations of 2.2% growth.

NASDAQ

NASDAQ increased as traders concentrated on the Meta stock's impressive performance. One may claim that the NASDAQ is ready to start a bull market since the index has increased by 20% from its December lows.


In today's trading session, Tesla, Amazon, and Alphabet are all up about 7% as investors rush to purchase mega cap stocks. Demand for tech stocks is high, and market sentiment is very bullish. Technically speaking, the chance of a retreat is rising since the RSI is in overbought zone.

Dow Jones,

Currently, Dow Jones is the least successful major index. The decline in healthcare stocks like UnitedHealth Group and Merck has a negative effect on Dow Jones' performance.


Medicare Advantage's projected reduced prices for 2024 are putting a lot of pressure on UnitedHealth Group. After the results report was released, Merck shares fell because the firm anticipates a fall in COVID-related revenues in 2023.